Fighting a Smarter War Against Cancer: A Three Part Symposium
Thursday, December 4
5:30pm - 9:00pm
Part one will present disease-specific in-depth updates on progress in research and care of GI cancer patients, from our Ruesch medical oncology team. The evening will include disease-specific sessions on colorectal, pancreas, hepatocellular and upper GI cancers, with a focus on improved diagnostics and new therapies. Content will focus on the emerging field of molecular diagnostics and therapeutics that will have an impact on patient care in the near future.
Friday, December 5
11:30am - 5:00pm
Part two of the symposium will focus on the fact that despite proven beneficial results for some patients, clinical research on gastrointestinal cancers in the United States and globally falls dramatically short of its potential. The vast majority of patients still receive only a standard of care that all too commonly proves ineffective. Cancer immunotherapy is an exciting area of active research in a range of treatment approaches including new monoclonal antibodies and cancer vaccines. As newer classes of immunotherapeutic agents are developed, a more sophisticated understanding of which patients will respond to the these new therapies is essential.
Part 3 - Patient Symposium
Saturday, December 6
8:30am - 3:00pm
The Patient Symposium on December 6 will bring patients and families disease-specific information and education, tools for managing their cancer care, and engage them in a discussion of the promise of emerging therapeutic approaches in cancer care and the concerns related to understanding the growing array of treatment options.